Acrivon Therapeutics (NASDAQ:ACRV) Stock Rating Raised to “Hold” at Wall Street Zen
Wall Street Zen upgraded shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) from a sell rating to a hold rating in a report released on Monday,Wall Street Zen reports. Separately, Weiss Ratings lowered shares of Acrivon Therapeutics from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, September 24th. Three […]
6 Oct 05:48 · The Markets Daily